You are here

  • Home
  • Archive
  • Volume 73, Issue 1
  • Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

 

Online download statistics by month:

Online download statistics by month: August 2013 to September 2024

AbstractFullPdf
Aug 2013949297403
Sep 2013744402371
Oct 2013451305308
Nov 2013333228190
Dec 20131516278398
Jan 2014888214376
Feb 2014426141258
Mar 2014409151189
Apr 2014284169196
May 2014197173135
Jun 2014184145129
Jul 201414114699
Aug 2014119150115
Sep 2014150152123
Oct 2014169183121
Nov 201413112892
Dec 201410610786
Jan 20151167178
Feb 201511210478
Mar 201511128593
Apr 20159611975
May 20158310584
Jun 20157611686
Jul 2015647974
Aug 2015607064
Sep 201511113484
Oct 2015617565
Nov 2015639783
Dec 2015947163
Jan 201611011894
Feb 20168394116
Mar 201699135112
Apr 20169210893
May 20167410685
Jun 2016797373
Jul 2016809882
Aug 2016658353
Sep 2016949581
Oct 20168710599
Nov 2016629770
Dec 2016767856
Jan 2017889579
Feb 20175410779
Mar 20171513560
Apr 20172018260
May 20171721767
Jun 20176617960
Jul 201722621050
Aug 201721518757
Sep 201721517557
Oct 201722921358
Nov 201718716779
Dec 201714513354
Jan 201821719458
Feb 201821618459
Mar 201824121746
Apr 201826623871
May 201822519460
Jun 201825222867
Jul 201818715362
Aug 201818018079
Sep 201816315954
Oct 201827524566
Nov 201824122274
Dec 201821319536
Jan 201975771977
Feb 201921020357
Mar 201924720365
Apr 201922119450
May 201921919745
Jun 201921218969
Jul 201923322576
Aug 201922621484
Sep 201922120373
Oct 2019285270104
Nov 201917716961
Dec 201923021664
Jan 202024020870
Feb 202020117074
Mar 202013913156
Apr 202018716164
May 202018916877
Jun 202017515063
Jul 202014112754
Aug 202014613397
Sep 202016215164
Oct 2020284213166
Nov 202023819994
Dec 202016714856
Jan 202121018573
Feb 202116514671
Mar 202122120483
Apr 202116816169
May 202115213773
Jun 202114614669
Jul 202115215261
Aug 202120120083
Sep 202115915979
Oct 20211069967
Nov 202113411761
Dec 202113312451
Jan 20221028437
Feb 202211711234
Mar 202216013644
Apr 202216813138
May 202212111533
Jun 202212011036
Jul 20221038625
Aug 202210610222
Sep 2022929154
Oct 202212511325
Nov 202211110425
Dec 2022908328
Jan 20231008820
Feb 2023948019
Mar 202313611240
Apr 2023625720
May 202313212343
Jun 2023856630
Jul 2023958436
Aug 202312110547
Sep 202323122228
Oct 202325924918
Nov 202332731914
Dec 202317316622
Jan 2024898830
Feb 202414111522
Mar 202414112492
Apr 202414613141
May 20241018953
Jun 202413012133
Jul 202411911841
Aug 202414314036
Sep 202412411533
Total252162106410741